Biofrontera Inc. Reports Positive Phase 2b Results Supporting Further Development of Ameluz® Photodynamic Therapy for moderate to severe Acne Vulgaris
March 9, 2026
Health
-
-
InspireMD to Announce Fourth Quarter and Full Year 2025 Financial Results
March 9, 2026
-
Shuttle Pharmaceuticals Announces $3.5 Million Public Offering
March 6, 2026
-
Prenetics Authorizes $40 Million Share Repurchase Program
March 6, 2026
-
Autonomix Medical Selected as Top Abstract at CRT 2026 and Selected for Podium Presentation of Clinical Feasibility and Outcomes of Novel Technique for Transvascular Peripheral RF Nerve Neurolysis
March 4, 2026
-
Exagen Inc. to Participate in Upcoming Investor Conferences
March 3, 2026
-
Microbot Medical® Confirms Continued Operational and Commercial Stability Amid Current Geopolitical Event
March 3, 2026
-
Talphera Announces 50% Enrollment Milestone in Ongoing NEPHRO-CRRT Registrational Trial
March 2, 2026
-
OneMedNet Announces Next Phase of Commercial Launch with its Real-World Data (RWD) Platform powered by Palantir Foundry
February 27, 2026
-
Healthcare Triangle Subsidiary QuantumNexis Inc. Launches its Dubai, UAE Operations to accelerate Digital Health Transformation across the GCC Countries
February 27, 2026
-
OneMedNet Partners with ViuHealth to Enhance Autoimmune Dataset Scale, Accelerating Recurring Revenue from Life Sciences and AI Customers
February 26, 2026
-
Avalon GloboCare’s Subsidiary Accepted into AMD AI Developer Program to Advance Next-Generation Media Infrastructure
February 26, 2026
-
Femasys Announces FemBloc® Permanent Birth Control Has Achieved MDSAP Certification, Advancing Global Market Access
February 26, 2026
-
Sharps Technology and The Tie Announce Strategic Collaboration to Advance Institutional Participation in the Solana Ecosystem
February 25, 2026
-
Intelligent Bio Solutions Successfully Manufactures and Ships First Readers with New Partner, Accelerating Scale and Driving Gross Margin Expansion in Anticipation of Planned U.S. Entry
February 25, 2026
-
Trinity Biotech Secures $25 Million Financing Commitment to Support Growth Initiatives
February 25, 2026